Asthma Spacers Market
                     Asthma Spacers Market- Size, Share, Outlook, and Opportunity Analysis, 2020- 
2027
Spacers (with metered dose inhalers) are used for treating respiratory diseases
such  as  asthma,  cystic  fibrosis,  and  chronic  obstructive  pulmonary  disease
(COPD).The increasing prevalence of respiratory diseases is expected to drive
the  global  asthma  spacers  market  growth  during  the  forecast  period.  For
instance, according to the World Health Organization (WHO), in 2017, around 65
million people suffered from moderate to severe chronic obstructive pulmonary
disease, among which 3 million die every year globally.
Request a sample copy of this report:- 
https://www.coherentmarketinsights.com/insight/request-sample/3020 
Respiratory diseases such as asthma and chronic obstructive pulmonary disease
(COPD) among others are highly prevalent worldwide. According to the World
Health Organization (WHO), the number of people suffering from asthma as of
November 2019 was around 235 million. According to the Centers for Disease
Control and Prevention (CDC), around 27 million Americans were suffering from
asthma  in  2016.  It  is  the  most  common  chronic  condition  among  American
children, where 1 child out of every 12 has asthma.
Furthermore, according to the National Heart, Lung, and Blood Institute, in 2014,
around  30%  of  children  in  the  U.S.  were  suffering  from  asthma.  Moreover,
according  to  the  same  source,  more  than  half  of  the  people  suffering  from
asthma experience a severe asthma attack each year, which leads to 450,000
hospitalizations, annually.
Furthermore,  asthma is  more prevalent  among the aging population which is
expected to facilitate the asthma spacers market growth in the U.S. According to
the World Population Ageing report, in 2017, the number of people aged 60 years
in the U.S. was 69,774, and the number is projected to reach 108,425 in 2050.
Furthermore, the global population aged 60 years was 962 million in 2017 and it
is expected to reach nearly 2.1 billion in 2050.
Asthma can be treated with bronchial thermoplasty which is a proven alternative
treatment.  It  is  used in  cases  where asthma drugs  do  not  show the  desired
effects or fail  to cure the condition.In bronchial thermoplasty, the inside of the
lungs’ airways are heated with electrodes to shrink the smooth muscle inside the
airways. It controls the ability of the airways to tighten, which makes breathing
easier and reduces incident of asthma attacks.
According to data published by the National Center for Biotechnology Information
in May 2015, several clinical trials have demonstrated the safety and efficacy of
bronchial thermoplasty in improving quality of life and reducing events of severe
asthma  attacks.  Thus,  availability  of  alternative  treatments  for  asthma  are
expected to hinder the global asthma spacers market growth.
North America accounted for the largest share in the asthma spacers market in
2019 as key players in the region are focusing on strategies such as mergers &
acquisitions, product innovation, joint ventures, collaborations, and partnership to
enhance  their  market  position.  For  instance,  in  May  2017,  Lupin  Limited
announced  a  partnership  between  its  American  subsidiary,  Lupin
Pharmaceuticals,  Inc.  (Lupin)  and  Albertsons  Companies,  to  provide  Lupin's
InspiraChamber (a valved holding chamber for the enhanced delivery of inhaled
aerosol  therapies)  to  patients  in  more  than  1,700  pharmacies  in  35  states,
including DC.
Furthermore, Asia Pacific is expected to observe the fastest growth during the
forecast period owing to launch of asthma spacers. For instance, in April 2019,
Cipla announced the launch of its inhaler, Niveoli, in India. It is India’s first extra-
fine particle Beclomethasone-Formoterol  combination Hydrofluoroalkane (HFA)
inhaler for adults. It is indicated for treatment of obstructive airway diseases such
as asthma.
Key players operating in the Asthma Spacers Market are GlaxoSmithKline Plc.,
Truedell  Medical  International,  Cipla Inc.,  Medical  Developments International,
PARI  Respiratory  Equipment,  Inc.,  Koninklijke  Philips  N.V.,  Clement  Clarke
International Ltd., and Lupin Limited.
Get the main link:-  https://www.coherentmarketinsights.com/market-insight/asthma-spacers-
market-3020 
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Visit our news Website: http://www.coherentchronicle.com/